View in EDS HTML Full Text PDF Full Text

Cost-benefit analysis of the National Immunization Program in Spain.

Saved in:
Bibliographic Details
Title: Cost-benefit analysis of the National Immunization Program in Spain.
Authors: Pérez A; Management, Hospital Nuestra Señora De Sonsoles (Complejo Asistencial De Avila), Ávila, Spain., Fernández Prada M; Preventive Medicine and Public Health, Hospital Vital Alvarez Buylla, Asturias, Spain., Cassinello N; Financial and Accounting Management, Universidad Pontificia Comillas, Madrid, Spain., Vallejo-Aparicio LA; Market Access, GSK, Madrid, Spain., García A; Market Access, GSK, Madrid, Spain., González A; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Durán A; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Zozaya N; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Fernández I; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Daheron M; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Hidalgo Á; Weber Foundation, Madrid, Spain.; University of Castilla La Mancha, Toledo, Spain., Beck E; Value Evidence and Outcomes, GSK, Wavre, Belgium., García Ruiz A; IBIMA Platform Bionand, Universidad de Málaga - IBIMA Platform Bionand, Málaga, Spain.
Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2385175. Date of Electronic Publication: 2024 Aug 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39161115
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-benefit analysis of the National Immunization Program in Spain.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pérez+A%22">Pérez A</searchLink>; Management, Hospital Nuestra Señora De Sonsoles (Complejo Asistencial De Avila), Ávila, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández+Prada+M%22">Fernández Prada M</searchLink>; Preventive Medicine and Public Health, Hospital Vital Alvarez Buylla, Asturias, Spain.<br /><searchLink fieldCode="AU" term="%22Cassinello+N%22">Cassinello N</searchLink>; Financial and Accounting Management, Universidad Pontificia Comillas, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Vallejo-Aparicio+LA%22">Vallejo-Aparicio LA</searchLink>; Market Access, GSK, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22García+A%22">García A</searchLink>; Market Access, GSK, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22González+A%22">González A</searchLink>; Health Economics and Market Access, Vivactis Weber, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Durán+A%22">Durán A</searchLink>; Health Economics and Market Access, Vivactis Weber, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Zozaya+N%22">Zozaya N</searchLink>; Health Economics and Market Access, Vivactis Weber, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández+I%22">Fernández I</searchLink>; Health Economics and Market Access, Vivactis Weber, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Daheron+M%22">Daheron M</searchLink>; Health Economics and Market Access, Vivactis Weber, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Hidalgo+Á%22">Hidalgo Á</searchLink>; Weber Foundation, Madrid, Spain.; University of Castilla La Mancha, Toledo, Spain.<br /><searchLink fieldCode="AU" term="%22Beck+E%22">Beck E</searchLink>; Value Evidence and Outcomes, GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22García+Ruiz+A%22">García Ruiz A</searchLink>; IBIMA Platform Bionand, Universidad de Málaga - IBIMA Platform Bionand, Málaga, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2385175. <i>Date of Electronic Publication: </i>2024 Aug 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39161115
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/21645515.2024.2385175
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2385175
    Titles:
      – TitleFull: Cost-benefit analysis of the National Immunization Program in Spain.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pérez A
      – PersonEntity:
          Name:
            NameFull: Fernández Prada M
      – PersonEntity:
          Name:
            NameFull: Cassinello N
      – PersonEntity:
          Name:
            NameFull: Vallejo-Aparicio LA
      – PersonEntity:
          Name:
            NameFull: García A
      – PersonEntity:
          Name:
            NameFull: González A
      – PersonEntity:
          Name:
            NameFull: Durán A
      – PersonEntity:
          Name:
            NameFull: Zozaya N
      – PersonEntity:
          Name:
            NameFull: Fernández I
      – PersonEntity:
          Name:
            NameFull: Daheron M
      – PersonEntity:
          Name:
            NameFull: Hidalgo Á
      – PersonEntity:
          Name:
            NameFull: Beck E
      – PersonEntity:
          Name:
            NameFull: García Ruiz A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 12
              Text: 2024 Dec 31
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2164-554X
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Human vaccines & immunotherapeutics
              Type: main
ResultId 1